Epidemic Outbreak of Catheter-Associated Bloodstream Infections among Patients Receiving Renal Replacement Therapy

Background:  Hemodialysis is the most common method of renal replacement therapy (RRT), however, its use is associated with risk of catheter-associated bloodstream infections (CABSI). Aims: diagnosis of epidemic trouble on CABSI in multidisciplinary adult hospital associated with the epidemic outbreak of CABSI in patients in RRT, and evaluation of complex of anti-epidemic measures. Materials and methods: in the framework of risk-oriented  epidemiological surveillance retrospective and operational epidemiological analysis of morbidity of CABSI and integrated clinical-epidemiological and microbiological examination of cases of outbreak was carried out. The study included patients with central venous catheter (n = 1295), patients receiving renal replacement therapy (n = 235), patients with CABSI (n = 48). 47 S aureus strains were studied, 520 researches were conducted. Results: An outbreak of CABSI of staphylococcal etiology (morbidity 33.01 per 1000 catheterized patients, 95% CI 21.31–44.71), had occurred from September to October 2016, involving 4 departments, manifested as 7 cases of CABSI in patients with RRT and actively identified 4 cases asymptomatic carriers of S. aureus in patients and one staff member of the Office of dialysis (incidence rate – 33.01 per 1000 catheterized  patients, 95% CI 44.71–21.31). Sources of infection have served as carriers of S. aureus among patients and staff. Contact pathway of transmission. Place of infection – dialysis department. Cause of the outbreak was the infection of patients in the RRT the hospital S. aureus strain circulating in this hospital with contamination of environmental objects and the formation of a reservoir among personnel and patients. To eliminate the outbreak, a set of measures was carried out, including optimization of monitoring of invasive manipulation of central venous catheterization, elimination of violations of epidemiological safety requirements, disinfection regime change, biological disinfection by bacterial phagocyte, decolonization of  S. aureus carriers by  bacterial phagocytes. The incidence rate decreased 1.8 times in 2017 compared to 2016, respectively, 12.5 per 1000, 95% CI 10.23–14.77) vs 22.8 per 1000  (95% CI: 22.5–23.1) of catheterized patients. Conclusion: the epidemic outbreak of CABSI in multidisciplinary hospital was identified and eliminated, The outbreak was the result of the circulation in the hospital of S. aureus hospital strain, which formed a reservoir among personnel and patients.

renal replacement therapy, dialysis, healthcare-associated infections, catheter-associated bloodstream infections, outbreak, S. aureus, risk-based epidemiological surveillance and control

1. Tomilina NA, Andrusev AM, Peregudova NG, et al. Renal replacement therapy for End Stage Renal Disease in Russian Federation, 2010-2015. Russian National Renal Replacement Therapy Registry Report of Russian Public Organization of Nephrologists «Russian Dialysis Society», Part 1. Nephrology and dialysis. 2017;4(19):1-95. (In Russ.)

2. Ryabov SI. editors. Nefrologiya. V21. T. 2. Pochechnaya nedostatochnost': rukovodstvo dlya vrachey. SPb.: SpetsLit; 2013. (In Russ.)

3. Shilov YeM, SmirnovAV, Kozlovskaya NL, editors. Nefrologiya: klinicheskiye rekomendatsii. Moscow: GEOTAR-Media; 2016. (In Russ.)

4. Yagudina RI, Serpik VG, Abdrashitova GT. Farmakoekonomicheskiy analiz okazaniya meditsinskoy pomoshchi bol'nym s khronicheskoy bolezn'yu pochek, nuzhdayushchimsya v provedenii zamestitel'noy pochechnoy terapii metodami peritoneal'nogo dializa i gemodializa v usloviyakh rossiyskogo zdravookhraneniya. Farmakoekonomika: teoriya i praktika. 2015;3(3):103-110. (In Russ.)

5. Liyanage T, Ninomiya T, Jha V, et al. Worldwide access to treatment for end stage kidney disease: a systematic review. Lancet. 2015;385(9981):1975-82. doi: 10.1016/S0140- 6736(14)61601-9

6. Bagirova NS. Infektsii, svyazannyye s vnutrisosudistymi ustroystvami: terminologiya, diagnostika, profilaktika i terapiya. Zlokachestvennyye opukholi. 2014;3:164-171. (In Russ).

7. Xue H, Ix JH, Wang W, et al. Hemodialysis access usage patterns in the incident dialysis year and associated catheter-related complications. Am J Kidney Dis. 2012; 61(1):123-30.

8. BD Bradbury, RB. Fissell, JM Albert, et al. Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Clin J Am Soc Nephrol. 2007;2:89-99. doi: 10.2215/CJN.01170905

9. Roca-Tey R, Arcos E, Comas J, et al. Tort Starting hemodialysis with catheter and mortality risk: Persistent association in a competing risk analysis. J Vasc Access. 2016; 17:20-28.

10. Berezhanskiy BV. Catheter-Associated Infections in Patients on Hemodialysis. Clinical microbiology and antimicrobial chemotherapy. 2012; 2(14):107-116. (In Russ.) 

11. Kvashnina DV, Kovalishena OV, Belyanina NA. Comprehensive clinical and etiological, as well as epidemiological characteristics of the catheter- associated blood circulation infections. Meditsinskiy al'manakh. 2017;4(49):41-45. (In Russ). doi: 10.21145/2499-9954-2017-4-41-45

12. Brusina EB, Kovalishena OV, Tsigelnik AM. Healthcare-Associated Infections: Trends and Prevention Prospectives. Epidemiology and Vaccine Prevention. 2017;16(4):73-80. (In Russ.) doi: 1031631/2073-3046-2017-16-4-73-80

13. Briko NI, Brusina EB, Zueva LP, et al. The strategy of ensuring epidemiological safety of medical activity. Vestnik Roszdravnadzora. 2017;4:15-21. (In Russ.)

14. Brusina YB, Barbarash OL. Upravleniye riskom infektsiy, svyazannykh s okazaniyem meditsinskoy pomoshchi (risk-menedzhment). Meditsinskiy al'manakh. 2015;5(40):22- 25. (In Russ.)

15. Merino JL, Bouarich H, Pita MJ, et al. Serratia marcescens bacteraemia outbreak in haemodialysis patients with tunnelled catheters due to colonisation of antiseptic solution. Experience at 4 hospitals. Nefrologia. 2016;36(6):667-673. doi: 10.1016/j.nefro.2016.05.009

16. Lo Cascio G, Bonora MG, Zorzi A, et al. A napkin-associated outbreak of Burkholderia cenocepacia bacteraemia in haemodialysis patients. J Hosp Infect. 2006;64(1):56-62. doi: 10.1016/j.jhin.2006.04.010

17. Diguio N, Chanet P, Hautemaniere A, et al. Control measures for a VRE outbreak in a haemodialysis unit. Nephrol Ther.2009;4:272-280. doi: 10.1016/S1769-7255(09)74558-4

18. Edens C, Wong J, Lyman M, et al. Hemodialyzer Reuse and Gram-Negative Bloodstream Infections. Am J Kidney Dis. 2017:69(6):726-733. doi: 10.1053/j.ajkd.2016.09.022

19. Federal'naya sluzhba po nadzoru v sfere zdravookhraneniya; FGBU «Tsentr monitoringa i kliniko-ekonomicheskoy ekspertizy» Roszdravnadzora. Predlozheniya (prakticheskiye rekomendatsii) po organizatsii vnutrennego kontrolya kachestva i bezopasnosti meditsinskoy deyatel'nosti v meditsinskoy organizatsii (statsionare). Moscow: B.i.; 2015. (In Russ.) Available at: http://www.mediexpo.ru/fileadmin/user_upload/content/pdf/pract_recom_org_vkk_i_bmd_v_mo.pdfAccessed: 01 Feb 2019.

20. Briko NI, Bikkulova DSH, Brusina YB, et al. Profilaktika kateter-assotsiirovannykh infektsiy krovotoka i ukhod za tsentral'nym venoznym kateterom (TSVK). Klinicheskiye rekomendatsii. Nizhniy Novgorod: Remedium Privolzh'ye; 2017. (In Russ.)

21. Horan T, Andrus M, Dudeck M. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. American Journal of Infection Control. 2008;36:309-332.

22. Opredeleniye chuvstvitel'nosti mikroorganizmov k antimikrobnym preparatam: klinicheskiye rekomendatsii. 2015. (In Russ.) Available at: http://www.antibiotic.ru/ minzdrav/files/docs/clrec-dsma2015.pdf Accessed: 01 Feb 2019.

23. Opredeleniye chuvstvitel'nosti mikroorganizmov k antibakterial'nym preparatam : metodicheskiye ukazaniya 4.2.1890-04. (In Russ.) Available at: http://docs.cntd.ru/ document/1200038583 A ccessed: 01 Feb 2019.

24. Aslanov BI, Zueva LP, Kaftyreva LA, et al. Ratsional'noye primeneniye bakteriofagov v lechebnoy i protivoepidemicheskoy praktike: federal'nyye klinicheskiye (metodicheskiye) rekomendatsii. Moscow: B.i; 2014. (In Russ.)

25. Shkarin VV, Kovalishena OV, Blagonravova AS, et al. Sposob opredeleniya chuvstvitel'nosti bakteriy k dezinfitsiruyushchim sredstvam pri monitoringe ustoychivosti k antimikrobnym preparatam v meditsinskikh organizatsiyakh: federal'nyye klinicheskiye rekomendatsii. Moscow: B.i.; 2015. (In Russ.)

26. Dezinfektologiya. Metodylaboratornykh issledovaniy i ispytaniydezinfektsionnykh sredstvdlya otsenki ikh effektivnosti i bezopasnosti: rukovodstvo 4.2.2643-10. (In Russ.) Available at: http://docs.cntd.ru/document/1200086231. Accessed: 01 Feb 2019.